Biotage AB (publ)
OTC: BITGF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Frederic Vanderhaegen
- Employees
- 622
- Headquarters
- Uppsala, Sweden
- IPO year
- 2010
- Market cap
- $1.2B
- Website
- https://www.biotage.com
Loading BITGF…
Loading profile data…Frequently asked questions about BITGF
What does Biotage AB (publ) (BITGF) do?
Biotage AB (publ) specializes in advanced separation science solutions for organic and analytical chemistry, biomolecular research, and industrial-scale applications. The company's comprehensive offerings include products for organic and peptide synthesis, flash chromatography, evaporation, and sample work-up, alongside a variety of flash system...
Where does BITGF trade?
Biotage AB (publ) (BITGF) trades on the Other OTC.
What sector is BITGF in?
Biotage AB (publ) (BITGF) operates in the Healthcare sector, specifically in the Medical - Instruments & Supplies industry.
Who is the CEO of Biotage AB (publ)?
Frederic Vanderhaegen is the chief executive officer of Biotage AB (publ) (BITGF).
Where is Biotage AB (publ) headquartered?
Biotage AB (publ) is headquartered in Sweden.
Does BITGF pay a dividend?
Yes — Biotage AB (publ) (BITGF) paid a trailing twelve-month dividend of USD 0.17 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did BITGF go public?
Biotage AB (publ) (BITGF) completed its initial public offering in 2010.